Potestio L, Piscitelli I, Fabbrocini G, Martora F, Ruggiero A, & Megna M. (2023). Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection. Dove Medical Press.
Chicago Style (17th ed.) CitationPotestio L, Piscitelli I, Fabbrocini G, Martora F, Ruggiero A, and Megna M. Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection. Dove Medical Press, 2023.
MLA (9th ed.) CitationPotestio L, et al. Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection. Dove Medical Press, 2023.
Warning: These citations may not always be 100% accurate.